insights_auto
Waarom is TMCI gestegen 3,73%?
Meer informatiechevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ 4,58
arrow_upward
+3,73%(+0,16) 1D
17 nov, 13:09:18 GMT-5 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor TMCI genereren…
Openen
US$ 4,44
Hoog
US$ 4,63
Laag
US$ 4,37
Beursw.
300,59 mln.
Gem. vol.
305,25K
Volume
167,68K
52 wk hoog
US$ 5,44
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Openen
US$ 4,44
Hoog
US$ 4,63
Laag
US$ 4,37
Beursw.
300,59 mln.
Gem. vol.
305,25K
Volume
167,68K
52 wk hoog
US$ 5,44
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Nieuwsartikelen
Van webbronnen en nieuwspartners
TradingView
·
1 uur geleden
QUICK SPARK: Walmart Stock Has Best 2-Month Run Against S&P 500 Since 1975
MarketWatch
·
36 minuten geleden
Why Salesforce’s stock is leading S&P 500 decliners amid tech jitters
Benzinga
·
1 uur geleden
S&P 500 Down 1%; Disney Posts Upbeat Earnings
BigGo Finance
·
1 uur geleden
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
Profiel
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Over Treace Medical Concepts, Inc